Amyloidoma of the cns: II. immunohistochemical and biochemical study

Ruben Vidal, J. Ghiso, G. Gallo, M. Cohen, P. L. Gambetti, Blas Frangione

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

We present the immunohistochemical and biochemical identification of an amyloidoma localized to the cerebral white matter in a patient who shows no evidence of systemic or extracranial localized amyloid deposits. Immunohistologic and immunochemical studies, using antibodies against biochemically different amyloid fibrils and amyloid–associated proteins, showed reactivity with antibodies only to lambda light chain and serum amyloid P–component. Amino acid sequence analysis of the purified amyloid fibrils extracted from the brain tumor indicates that the amyloid protein is an unusual immunoglobulin lambda light chain, starting at residue five of the variable domain. These fibrils consist of lambda chain fragments of different lengths (10 to 30 kd) very likely arising by polymerization of the amyloid subunit or sequential proteolytic cleavage of the light chain, or both. After exposure to denaturing agents, the 10–kd subunit retains the characteristics of native amyloid fibrils by electron microscopy.

Original languageEnglish (US)
Pages (from-to)2024-2028
Number of pages5
JournalNeurology
Volume42
Issue number10
StatePublished - 1992
Externally publishedYes

Fingerprint

Amyloid
Immunoglobulin lambda-Chains
Amyloidogenic Proteins
Light
Antibodies
Protein Sequence Analysis
Amyloid Plaques
Brain Neoplasms
Polymerization
Electron Microscopy
Serum
Protein
Proteins

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Vidal, R., Ghiso, J., Gallo, G., Cohen, M., Gambetti, P. L., & Frangione, B. (1992). Amyloidoma of the cns: II. immunohistochemical and biochemical study. Neurology, 42(10), 2024-2028.

Amyloidoma of the cns : II. immunohistochemical and biochemical study. / Vidal, Ruben; Ghiso, J.; Gallo, G.; Cohen, M.; Gambetti, P. L.; Frangione, Blas.

In: Neurology, Vol. 42, No. 10, 1992, p. 2024-2028.

Research output: Contribution to journalArticle

Vidal, R, Ghiso, J, Gallo, G, Cohen, M, Gambetti, PL & Frangione, B 1992, 'Amyloidoma of the cns: II. immunohistochemical and biochemical study', Neurology, vol. 42, no. 10, pp. 2024-2028.
Vidal R, Ghiso J, Gallo G, Cohen M, Gambetti PL, Frangione B. Amyloidoma of the cns: II. immunohistochemical and biochemical study. Neurology. 1992;42(10):2024-2028.
Vidal, Ruben ; Ghiso, J. ; Gallo, G. ; Cohen, M. ; Gambetti, P. L. ; Frangione, Blas. / Amyloidoma of the cns : II. immunohistochemical and biochemical study. In: Neurology. 1992 ; Vol. 42, No. 10. pp. 2024-2028.
@article{c07388b206554ee288acea3586f3d05a,
title = "Amyloidoma of the cns: II. immunohistochemical and biochemical study",
abstract = "We present the immunohistochemical and biochemical identification of an amyloidoma localized to the cerebral white matter in a patient who shows no evidence of systemic or extracranial localized amyloid deposits. Immunohistologic and immunochemical studies, using antibodies against biochemically different amyloid fibrils and amyloid–associated proteins, showed reactivity with antibodies only to lambda light chain and serum amyloid P–component. Amino acid sequence analysis of the purified amyloid fibrils extracted from the brain tumor indicates that the amyloid protein is an unusual immunoglobulin lambda light chain, starting at residue five of the variable domain. These fibrils consist of lambda chain fragments of different lengths (10 to 30 kd) very likely arising by polymerization of the amyloid subunit or sequential proteolytic cleavage of the light chain, or both. After exposure to denaturing agents, the 10–kd subunit retains the characteristics of native amyloid fibrils by electron microscopy.",
author = "Ruben Vidal and J. Ghiso and G. Gallo and M. Cohen and Gambetti, {P. L.} and Blas Frangione",
year = "1992",
language = "English (US)",
volume = "42",
pages = "2024--2028",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Amyloidoma of the cns

T2 - II. immunohistochemical and biochemical study

AU - Vidal, Ruben

AU - Ghiso, J.

AU - Gallo, G.

AU - Cohen, M.

AU - Gambetti, P. L.

AU - Frangione, Blas

PY - 1992

Y1 - 1992

N2 - We present the immunohistochemical and biochemical identification of an amyloidoma localized to the cerebral white matter in a patient who shows no evidence of systemic or extracranial localized amyloid deposits. Immunohistologic and immunochemical studies, using antibodies against biochemically different amyloid fibrils and amyloid–associated proteins, showed reactivity with antibodies only to lambda light chain and serum amyloid P–component. Amino acid sequence analysis of the purified amyloid fibrils extracted from the brain tumor indicates that the amyloid protein is an unusual immunoglobulin lambda light chain, starting at residue five of the variable domain. These fibrils consist of lambda chain fragments of different lengths (10 to 30 kd) very likely arising by polymerization of the amyloid subunit or sequential proteolytic cleavage of the light chain, or both. After exposure to denaturing agents, the 10–kd subunit retains the characteristics of native amyloid fibrils by electron microscopy.

AB - We present the immunohistochemical and biochemical identification of an amyloidoma localized to the cerebral white matter in a patient who shows no evidence of systemic or extracranial localized amyloid deposits. Immunohistologic and immunochemical studies, using antibodies against biochemically different amyloid fibrils and amyloid–associated proteins, showed reactivity with antibodies only to lambda light chain and serum amyloid P–component. Amino acid sequence analysis of the purified amyloid fibrils extracted from the brain tumor indicates that the amyloid protein is an unusual immunoglobulin lambda light chain, starting at residue five of the variable domain. These fibrils consist of lambda chain fragments of different lengths (10 to 30 kd) very likely arising by polymerization of the amyloid subunit or sequential proteolytic cleavage of the light chain, or both. After exposure to denaturing agents, the 10–kd subunit retains the characteristics of native amyloid fibrils by electron microscopy.

UR - http://www.scopus.com/inward/record.url?scp=0026802980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026802980&partnerID=8YFLogxK

M3 - Article

C2 - 1383872

AN - SCOPUS:0026802980

VL - 42

SP - 2024

EP - 2028

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 10

ER -